- Home
- WLGS vs SBFM Comparison
WLGS vs SBFM Comparison
Compare WLGS & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- SBFM
- Stock Information
- Founded
- WLGS 1981
- SBFM 2006
- Country
- WLGS Hong Kong
- SBFM United States
- Employees
- WLGS N/A
- SBFM N/A
- Industry
- WLGS Engineering & Construction
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- SBFM Health Care
- Exchange
- WLGS Nasdaq
- SBFM Nasdaq
- Market Cap
- WLGS 4.4M
- SBFM 6.7M
- IPO Year
- WLGS 2023
- SBFM N/A
- Fundamental
- Price
- WLGS $0.04
- SBFM $1.51
- Analyst Decision
- WLGS
- SBFM Strong Buy
- Analyst Count
- WLGS 0
- SBFM 1
- Target Price
- WLGS N/A
- SBFM $15.00
- AVG Volume (30 Days)
- WLGS 65.2M
- SBFM 192.4K
- Earning Date
- WLGS 08-14-2025
- SBFM 08-15-2025
- Dividend Yield
- WLGS N/A
- SBFM N/A
- EPS Growth
- WLGS N/A
- SBFM N/A
- EPS
- WLGS N/A
- SBFM N/A
- Revenue
- WLGS $3,951,649.00
- SBFM $36,234,578.00
- Revenue This Year
- WLGS N/A
- SBFM $192.48
- Revenue Next Year
- WLGS N/A
- SBFM N/A
- P/E Ratio
- WLGS N/A
- SBFM N/A
- Revenue Growth
- WLGS N/A
- SBFM 35.51
- 52 Week Low
- WLGS $0.03
- SBFM $1.17
- 52 Week High
- WLGS $9.66
- SBFM $6.99
- Technical
- Relative Strength Index (RSI)
- WLGS 31.65
- SBFM 49.86
- Support Level
- WLGS $0.04
- SBFM $1.43
- Resistance Level
- WLGS $0.08
- SBFM $1.61
- Average True Range (ATR)
- WLGS 0.01
- SBFM 0.12
- MACD
- WLGS 0.01
- SBFM 0.00
- Stochastic Oscillator
- WLGS 23.18
- SBFM 32.78
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.